A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics

British Journal of Cancer

Volumn 85, Issue 10, 2001, Pages 1444-1451

  Sculier, J P ^a   Paesmans, M ^a   Lecomte, J ^a   Van Cutsem, O ^a   Lafitte, J J ^a   Berghmans, T ^a   Koumakis, G ^a   Florin, M C ^a   Thiriaux, J ^a   Michel, J ^a   Giner, V ^a   Berchier, M C ^a   Mommen, P ^a   Ninane, V ^a   Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Accelerated chemotherapy; GM CSF; Small cell lung cancer

Indexed keywords

COTRIMOXAZOLE; EPIRUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; MESNA; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINDESINE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INFECTION; INTERMETHOD COMPARISON; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; ENDPOINT DETERMINATION; ETOPOSIDE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VINDESINE;

EID: 0035900803     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.2114     Document Type: Article

References (28)

1. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
2. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: A prospective phase III randomized study of the Southwest Oncology Group
3. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
4. Trimethoprim/sulfamethoxazole versus placebo: A double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung
5. Cotrimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer
6. Tables of the number of patients required in clinical trials using the logrank test
7. On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial
8. Doscranging study of recombinant human granulocyte-rnacrophage colony-stimulating factor in small-cell lung carcinoma
9. Management of small cell lung cancer: Current state of the art
10. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1)
11. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2)
12. Revue critique des éudes randomisées évaluant le rôle de la radiothérapie thoracique adjuvanteàla chimiothérapie dans le traitement du cancer bronchiqueàpetites cellules au stade limité
13. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and metaanalysis
14. 2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
15. Prognostic factors for patients with small cell lung carcinoma: Analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years
16. A meta-analysis of thoracic radiotherapy for small-cell lung cancer
17. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: A multicenter randomized phase III study
18. High-dose chemotherapy of small-cell lung cancer with and without bone marrow transplantation
19. A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
20. Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: A phase III randomized study conducted by the European Lung Cancer Working Party
21. Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer
22. Maintenance chemotherapy for small cell lung cancer: A critical review of the literature
23. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: A prospective randomized study of 300 patients
24. New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment
25. Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: Results of a British Medical Research Council Multicenter Randomized Trial
26. Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
27. Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: A long-term follow-up
28. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis